v3 Template
G

Gero

Biotechnology and Longevity ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$6.0M
Funding Rounds
2
Last Funding
2024-06-12

About Gero

Gero is a therapeutics company focused on targeting the root physics of aging using AI and physics to add decades of healthy life. Their mission is to intercept functional decline before it manifests as disease, restore resilience, and double healthy human lifespan within a single generation.

Products & Services

AI-Driven Drug Discovery Platform:A platform trained on over 100M longitudinal medical records to map aging trajectories and reveal causal pathways for diseases and aging, using physics-informed, interpretable AI models grounded in thermodynamics.
Therapeutics for Age-Related Diseases:Developing first-in-class therapeutics to treat chronic age-related diseases by restoring systemic resilience and controlling the rate of aging and disease progression, both in-house and through collaborations with pharmaceutical companies.
ProtoBind-Diff:Launched in 2025, this is the first AI model for structure-free drug design using only protein sequence.

Specialties

AI in Drug Discovery Physics-Informed Modeling Aging Research Therapeutics for Age-Related Diseases Resilience and Healthspan Extension

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Prize
T: -
FT: Prize 		A: 10000
MR: -
FA: 10,000
FAN: 10000 		D: 2024-06-12
FD: 2024-06-12 		-
2 RT: Series A extension
T: -
FT: Series A extension 		A: 6000000
MR: -
FA: $6M
FAN: 6000000 		D: 2023-10-18
FD: 2023-10-18 		3 investors
Prize Latest
2024-06-12
$10K
Series A extension 2023-10-18
$6.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Peter Fedichev

Physicist

LinkedIn (Pro only)
M

Maxim Kholin

Co-founder of Gero

LinkedIn (Pro only)
A

Alex Kadet

Chief Business Officer

LinkedIn (Pro only)
A

Aleksandr Sviridov

Chief Operating Officer

Y

Yuri Melnichek

Board Member

Y

Yury Melnichek

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Gero Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
gero.ai
Industries
Biotechnology and Longevity
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro